Feb 27, 2017 at 14:23 | Source: Moneycontrol.com
Astellas submitted a new drug application (NDA) with the Ministry of Health, Labour and Welfare in Japan for extended-release tablets of quetiapine fumarate for the indication of improvement of depressive symptoms associated with bipolar disorder.
Feb 27, 2017 at 12:24 | Source: PTI
In a BSE filing, Lupin said "its Japanese subsidiary Kyowa Pharmaceutical Industry Co, Ltd and Astellas Pharma Inc have entered into an agreement providing Kyowa the exclusive right to distribute and promote extended-release tablets of quetiapine fumarate in Japan".
Feb 27, 2017 at 12:00 | Source: Moneycontrol.com
Lupin's Japanese subsidiary Kyowa Pharmaceutical Industry and Astellas Pharma Inc. have entered into an agreement providing Kyowa the exclusive right to distribute and promote extended-release tablets of quetiapine fumarate in Japan.
Feb 27, 2017 at 11:52 | Source: Moneycontrol.com
Cadilas subsidiary, Zydus Cadila, received regulatory approvals to launch tetravalent inactivated influenza vaccine for seasonal flu in India. Meanwhile, Zydus received the approval from US Food and Drug Administration (FDA) for Linezolid tablets. These are used to treat skin infections and pneumonia.
Feb 27, 2017 at 07:48 | Source: PTI
Instead, Samsung is spotlighting new Android and Windows tablets after delaying the Galaxy S8 smartphone, an indirect casualty of the unprecedented September recall of the fire-prone Note 7 phone.
Feb 22, 2017 at 09:02 | Source: PTI
"Panasonic Toughpad enjoys a 65 percent leadership in rugged notebooks and tablets and with the introduction of the new products in the Toughbook and Toughpad series we aim to increase our market share to over 70 percent in next years", said Gunjan Sachdev, National Business Head, Toughbook and Toughpad Division.
Feb 21, 2017 at 08:21 | Source: Reuters
After flagging a USD 6.3 billion writedown on its US nuclear unit earlier this month, the conglomerate says it is now prepared to sell a majority stake or even all of the NAND memory unit, which makes chips for mobiles and tablets and is its most valuable business. Previously it had planned to sell 19.9 percent.
Feb 17, 2017 at 14:26 | Source: PTI
Drug firm Zydus Cadila has received approval from the US health regulator to market fluconazole tablets used for the treatment of fungal infections.
Feb 16, 2017 at 15:44 | Source: Moneycontrol.com
Lupin has received final USFDA approval for ANDA Moxifloxacin Hydrochloride Tablets, 400 mg. Generic of Avlox Tablets of Bayer Healthcare Pharmaceuticals, Inc.
Feb 15, 2017 at 14:40 | Source: PTI
According to a notification issued by the US Food and Drug Authority, Dr Reddy's is recalling Olanzapine tablets USP of 2.5 mg while Aurobindo is recalling Pantoprazole Sodium for Injection, 40mg per vial from the market.